REPLY: Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy

JACC CardioOncol. 2023 Feb 21;5(1):157. doi: 10.1016/j.jaccao.2022.12.004. eCollection 2023 Feb.
No abstract available